Tahata, Yuki
Hikita, Hayato
Mochida, Satoshi
Enomoto, Nobuyuki
Ido, Akio
Kuroda, Hidekatsu
Miki, Daiki
Kurosaki, Masayuki
Hiasa, Yoichi
Sakamori, Ryotaro
Kawada, Norifumi
Yamashita, Taro
Suda, Goki
Yatsuhashi, Hiroshi
Yoshiji, Hitoshi
Kato, Naoya
Takami, Taro
Nakao, Kazuhiko
Matsuura, Kentaro
Asahina, Yasuhiro
Itoh, Yoshito
Tateishi, Ryosuke
Nakamoto, Yasunari
Kakazu, Eiji
Terai, Shuji
Shimizu, Masahito
Ueno, Yoshiyuki
Akuta, Norio
Miyazaki, Masanori
Nozaki, Yasutoshi
Kabayama, Masayuki
Sobue, Satoshi
Moriuchi, Akihiro
Miyaki, Tomokatsu
Kodama, Takahiro
Tatsumi, Tomohide
Yamada, Tomomi
Takehara, Tetsuo http://orcid.org/0000-0001-5036-3457
Funding for this research was provided by:
Gilead Sciences
Japan Agency for Medical Research and Development (JP23fk0210113)
Osaka University
Article History
Received: 18 July 2023
Accepted: 27 August 2023
First Online: 13 October 2023
Declarations
:
: Satoshi Mochida received lecture fees from Gilead Sciences, Inc., AbbVie GK., ASKA Pharmaceutical Co., Ltd., Toray Industries Inc., Otuska Pharmaceutical Co., Ltd. and Eisai Co., Ltd. Masayuki Kurosaki received lecture fees from Gilead, AbbVie, Eisai, Chugai, AstraZeneca, Lilly and Takeda. Norifumi Kawada received research grants from AstraZeneca plc., Bristol Myers Squibb., Glaxosmithkline plc., MSD co., ltd., Gilead Sciences. Inc. and NovoNordisk pharma Ltd., scholarship grants from AbbVie GK, Eisai Co., Ltd. and Otsuka Pharmaceutical Co. and received lecture fees from AbbVie GK, Gilead Sciences, Inc. and MSD Co., Ltd. Goki Suda received research grants from Gilead Sciences Inc. Hitoshi Yoshiji received lecture fees from Gilead Sci. Naoya Kato received research grants from AbbVie G.K., scholarship grants from Gilead Sciences Inc., and lecture fees from Gilead Sciences, Inc. and AbbVie G.K. Taro Takami received lecture fees from Gilead Sciences, Inc. Yasuhiro Asahina belongs to a donation-funded department funded by Fujirebio Inc. and Abbott Japan LLC. Yoshito Itoh received research grants from Merck Sharp and Dohme., scholarship grants from AbbVie Inc. and Takeda Pharm. Co.Ltd. and lecture fees from AbbVie Inc and Gilead Sciences Inc. Shuji Terai received lecture fees from Otsuka, AbbVie, Asuka, Daiichisankyo, Chiomu Takedansen and Gilead. Yoshiyuki Ueno received lecture fees from AbbVie Inc. Norio Akuta received lecture fees from AbbVie Inc. Tetsuo Takehara received research grants and lecture fees from AbbVie GK. and Gilead Sciences, Inc. All other authors declare that they have no conflicts of interest to disclose.
: University Hospital Medical Information Network (UMIN: 36150).